Treatment of Comorbid Anxiety and Depression

Introduction to Treatment Approach

The American College of Oncology recommends treating depression first when both anxiety and depressive symptoms are present, using cognitive behavioral therapy (CBT) or behavioral activation as first-line interventions, with pharmacotherapy reserved for specific circumstances 1
A unified protocol that combines CBT treatments for both depression and anxiety can be used as an alternative 1, 2

The stepped-care model selects the most effective and least resource-intensive intervention based on symptom severity, with mild to moderate symptoms starting with psychological/behavioral interventions 3
Moderate to severe symptoms may require more intensive psychological treatment or combination approaches 4
Severe symptoms with psychotic features should strongly consider pharmacotherapy 1, 2

Cognitive Behavioral Therapy (CBT) is the primary recommended psychological treatment, with individual therapy prioritized over group therapy due to superior clinical and economic effectiveness 6
Behavioral Activation (BA) is equally effective as CBT and should be considered as an alternative first-line option 7
Self-help with support based on CBT principles can be offered if patients decline face-to-face therapy 6

SSRIs are the primary pharmacologic choice, with escitalopram and sertraline as first-line SSRI options 6
Second-generation antidepressants show similar efficacy across agents for treating depression with anxiety symptoms 9, 10, 8
Venlafaxine (SNRI) showed superior response and remission rates compared to fluoxetine in one trial for patients with depression and anxiety 10, 8, 5

Regular assessment schedules for psychological treatment include pretreatment, 4 weeks, 8 weeks, and end of treatment, using standardized validated instruments 1, 2
Pharmacologic treatment assessment includes 4 and 8 weeks using standardized instruments, monitoring symptom relief, side effects, adverse events, and patient satisfaction 1, 2, 3
Treatment adjustment protocols include adding a psychological or pharmacologic intervention to single treatment, changing the medication, or referring to individual therapy if using group therapy 1, 2, 3

Avoid starting pharmacotherapy as first-line when psychological treatment is accessible 7
Failing to assess treatment response regularly with validated instruments 1
Waiting beyond 8 weeks to adjust ineffective treatment 1, 2
Ignoring barriers to treatment access and follow-through 1, 3